Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.54 |
| ▸ | PPARA | Q07869 | 4/20 | 0.54 |
| ▸ | SUV39H2 | Q9H5I1 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | DRD2 | P14416 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7959540 | 0.92 | PPARG (0.53) | PPARGPPARASUV39H2SIGMAR1DRD2 | |
| SCHEMBL7957405 | 0.83 | TNF (0.50) | DRD2 | |
| SCHEMBL7957644 | 0.81 | DRD2 (0.61) | PPARGPPARASIGMAR1DRD2HTR1A | |
| SCHEMBL7960280 | 0.81 | DRD2 (0.46) | PPARGPPARASUV39H2SIGMAR1DRD2 | |
| SCHEMBL8570913 | 0.81 | PPARG (0.54) | PPARGPPARASUV39H2SIGMAR1DRD2 | |
| SCHEMBL7949197 | 0.81 | PPARG (0.47) | PPARGPPARASIGMAR1DRD2KDM4E | |
| SCHEMBL7961282 | 0.80 | SIGMAR1 (0.52) | PPARGPPARASUV39H2SIGMAR1DRD2 | |
| SCHEMBL7949222 | 0.80 | DRD2 (0.49) | PPARGPPARASUV39H2SIGMAR1DRD2 | |
| SCHEMBL3766147 | 0.79 | PPARG (0.52) | PPARGPPARASIGMAR1DRD2HTR1A | |
| SCHEMBL7957641 | 0.79 | TRPV1 (0.44) | PPARGPPARASUV39H2SIGMAR1DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187774-B1 | N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| EP-0885883-A1 | FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-12-23 | — | — | EP | disclosed |